Clincosm LogoSign in Get a demo

breast cancer metastatic

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon

Not yet recruiting
  • Breast Cancer
  • +4 more
  • SV-BR-1-GM
  • +4 more
  • Port Jefferson Station, New York
    New York Cancers & Blood Specialists
Oct 2, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Breast Cancer Stage IV, Breast Cancer Metastatic, Communication Trial in San Pedro Garza Garcia (Communication model)

Not yet recruiting
  • Breast Cancer Stage IV
  • +2 more
  • Communication model
  • San Pedro Garza Garcia, Nuevo Leon, Mexico
    Hospital Zambrano Hellion
Apr 28, 2023

Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

Not yet recruiting
  • Breast Cancer Metastatic
  • Leptomeningeal Metastasis
  • Tucatinib Oral Tablet
  • +2 more
  • (no location specified)
Mar 23, 2023

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)

Recruiting
  • Breast Cancer Metastatic
  • Irinotecan Hydrochloride
  • Badalona, Spain
  • +19 more
Jan 18, 2023

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)

Recruiting
  • Breast Cancer
  • +3 more
  • SV-BR-1-GM
  • +3 more
  • Newport Beach, California
  • +9 more
Dec 8, 2022

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Screening For BCRL In Targeted Therapy For Breast Cancer

    Recruiting
    • Lymphedema
    • +10 more
    • Perometer
    • SOZO device
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 21, 2022

    Atezolizumab With Nab-paclitaxel for Triple-negative Stage IV

    Completed
    • Breast Cancer Metastatic
    • Atezolizumab in combination with nab-paclitaxel
    • Roma, RM, Italy
      Policlinico A. Gemelli - IRCCS
    Nov 2, 2022

    Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (Olaparib, Physician's choice chemo)

    Active, not recruiting
    Has Results
    • Breast Cancer Metastatic
    • +2 more
    • San Diego, California
    • +171 more
    Oct 10, 2022

    Breast Cancer Metastatic Trial in United States (Paclitaxel, Pelareorep, Avelumab)

    Active, not recruiting
    • Breast Cancer Metastatic
    • Miami, Florida
    • +17 more
    Sep 1, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

    Active, not recruiting
    • Breast Cancer Metastatic
    • Los Angeles, California
    • +24 more
    Aug 10, 2022

    Breast Cancer Patients Trend Distinctive Regional

    Completed
    • Breast Cancer
    • +4 more
      • Karachi, Sindh, Pakistan
        Sindh Institute of Urology and Transplantation
      Jul 18, 2022

      Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of

      Not yet recruiting
      • Breast Cancer Metastatic
      • TSL-1502 capsules(low dose)
      • +2 more
      • Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Jun 13, 2022

      Breast Cancer Metastatic Trial in Worldwide (Amcenestrant, Fulvestrant, Anastrozole)

      Active, not recruiting
      • Breast Cancer Metastatic
      • Birmingham, Alabama
      • +121 more
      Apr 28, 2022

      Breast Cancer Metastatic Trial in Sweden, United Kingdom (Palbociclib, Fulvestrant, Capecitabine)

      Active, not recruiting
      • Breast Cancer Metastatic
      • Göteborg, Sweden
      • +8 more
      Mar 29, 2022

      Breast Cancer Metastatic, Breast Cancer Female, Breast Cancer Recurrent Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

      Completed
      • Breast Cancer Metastatic
      • +2 more
      • Hanoi, Vietnam
      • +1 more
      Mar 19, 2022

      Breast Cancer Metastatic, Breast Cancer Recurrent, Breast Cancer Female Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

      Completed
      • Breast Cancer Metastatic
      • +2 more
      • Hanoi, Vietnam
      • +1 more
      Mar 19, 2022

      Breast Cancer Metastatic Trial in Guangzhou (Tamoxifen Oral Product)

      Completed
      Has Results
      • Breast Cancer Metastatic
      • Tamoxifen Oral Product
      • Guangzhou, Guangdong, China
        Sun Yat-sen University, Cancer Center
      Mar 25, 2022

      HR+ Metastatic Breast Cancer, Breast Cancer, Breast Cancer Metastatic Trial in Durham (GMI-1359)

      Terminated
      • HR+ Metastatic Breast Cancer
      • +2 more
      • Durham, North Carolina
        Duke University Medical Center
      Mar 7, 2022